This contract will support component a of the collaborative influenza vaccine innovation centers (CIVICS) program to design and evaluate innovative influenza vaccine approaches, based on principles of…
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00051
- Awardee
-
Icahn School Of Medicine At Mount Sinai UEI C8H9CNG1VBD9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $110,068,787
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA2018 Solicitation number
- Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Award Notice · Posted Jun 1, 2018
- Contract value 73% obligated
-
- $110,865,639.82 Current, with exercised options
- $150,228,003.82 Potential, with all options
- Completion date 91% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10029, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$300,632 | |
| Exercise an Option | $2,840,455 | |
| Funding Only Action | -$2,014 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $852,822 | |
| Funding Only Action | -$37,182 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $10,000,000 | |
| Exercise an Option | $1,984,532 | |
| Exercise an Option | $4,396,768 | |
| Exercise an Option | $2,001,856 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $256,013 | |
| Exercise an Option | $12,373,066 | |
| Exercise an Option | $11,771,933 | |
| Supplemental Agreement for work within scope | $791,022 | |
| Exercise an Option | $726,338 | |
| Supplemental Agreement for work within scope | $707,827 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,049,110 | |
| Supplemental Agreement for work within scope | -$524,294 | |
| Exercise an Option | $10,707,222 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $4,736,320 | |
| Exercise an Option | $10,914,622 | |
| Exercise an Option | $457,311 | |
| Exercise an Option | $457,311 | |
| Exercise an Option | $1,384,074 | |
| Supplemental Agreement for work within scope | $1,084,986 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $191,799 | |
| Supplemental Agreement for work within scope | $6,408,099 | |
| Exercise an Option | $10,649,110 | |
| Exercise an Option | $3,051,550 | |
| Exercise an Option | $1,138,763 | |
| Original award | $10,000,000 |
Show all 42
About this award
The National Institute of Allergy and Infectious Diseases awarded a $150.228 million definitive contract to Icahn School of Medicine at Mount Sinai on September 10, 2019, under cost-no-fee pricing to support Component A of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program, which designs and evaluates innovative influenza vaccine approaches based on principles of influenza immunity to achieve durable, robust protection.
Place of performance is New York, New York. The ultimate completion date is July 9, 2027. The originating solicitation describes the development and evaluation of novel influenza vaccine candidates and immunogens, including chimeric hemagglutinin constructs, consensus antigens, mRNA platforms, recombinant neuraminidase-based vaccines, DNA-encoded vaccines, and adjuvant formulations, alongside comprehensive preclinical and clinical evaluation of immune responses (B cell, T cell, and innate immunity) and protective efficacy in animal models and human subjects.
Service Contract Inventory data show the contract invoiced $5.5 million in FY2020, $16 million in FY2021, $16 million in FY2023, $14.5 million in FY2024, and $17.9 million in FY2025. The most recent reported fiscal year (FY2025) delivered 66.7 FTEs across 138,664 contractor hours at a derived government-paid rate of $128.89 per hour. Subcontractors performed approximately 68 percent of hours in FY2025, with 23 subcontractors named. Government-paid hourly rates declined from $138.99 per hour in FY2021 to $128.89 per hour in FY2025.
Subcontractors include the Regents of the University of Minnesota, Sustainable Sciences Institute, Universität für Bodenkultur Wien, The Washington University, Vivaldi Biosciences Inc., Scripps Research Institute, and numerous academic research institutions engaged across vaccine immunogen design, preclinical testing, immune response characterization, and clinical trial coordination.
Description
This contract will support component a of the collaborative influenza vaccine innovation centers (CIVICS) program to design and evaluate innovative influenza vaccine approaches, based on principles of influenza immunity, that achieve durable, robust
Subawards
Show all 27
Quick answers
Who was awarded contract 75N93019C00051?
75N93019C00051 was awarded to Icahn School Of Medicine At Mount Sinai by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2019.
How much is contract 75N93019C00051 worth?
The government has obligated $110,068,787 on 75N93019C00051. Its current value, with exercised options, is $110,865,640. Its potential value, with all options, is $150,228,004.
Was contract 75N93019C00051 competed?
The extent of competition for 75N93019C00051 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award